News Releases

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

Anixa Biosciences to Present at SITC Annual Meeting

October 29, 2018

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

October 24, 2018

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

October 22, 2018

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

1
2
3
4
Next »

Latest News & Events

Nov 7, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

Read More...

Nov 5, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

Read More...

Oct 28, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.